How crucial is an advisory board to your company? It is a must for us at Nevvon.
I am proud to announce the 1st advisory board member to Nevvon.

Neil Closner has over two decades of start-up, technology and health care experience and currently serves as Chief Executive Officer and a director of LAVVAN Inc., a company that manufactures pure cannabinoid isolates through a yeast-based cellular agriculture platform. Immediately prior, from February 2013 to July 2018, he was the founder, Chief Executive Officer and a director of Canada-based MedReleaf Corp., one of the largest providers of medical cannabis in Canada which after completing the largest IPO in the sector’s history in 2017 was acquired in July 2018 for $3.2 billion. Prior to establishing MedReleaf Corp., Mr. Closner served as Vice President of Business Development at Toronto’s Mount Sinai Hospital, where he launched and managed a number of entrepreneurial enterprises within the hospital. Mr. Closner began his career as a health care-focused investment banker with Salomon Smith Barney (now Citigroup) and has also served as the founder, Chief Executive Officer and/or director of more than half a dozen technology and health care-related start-up companies.

(continued in comments)